Is Bariatric Surgery Safe to Perform in Patients with Chronic Liver Disease? A National Cross-Sectional Study
- 17 May 2025
- journal article
- research article
- Published by Springer Nature in Obesity Surgery
- Vol. 35 (6) , 2264-2273
Abstract
Background Obesity is a worldwide epidemic and is pervasive in the liver disease community. Given that liver disease is both caused and worsened by obesity, our study assesses the risks of bariatric surgery in patients with chronic liver disease. Methods This retrospective study using the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program 2023 database includes adult patients who underwent minimally invasive sleeve gastrectomy, Roux-en-Y gastric bypass, or gastric band placement procedures. Liver disease (LD) includes a spectrum of severity (borderline to moderate) and etiologies (including steatosis). LD and non-liver disease (non-LD) cohorts were compared using Chi-square and t-tests. Univariate and multivariate analyses were performed using logistic regression. Results Our sample of 201,605 patients included 22,476 (11.2%) LD and 179,129 (88.9%) non-LD patients. Overall mean body mass index was 44.68 kg/m2 (SD 7.86). The mortality rates were no different between groups (0.07% and 0.07%, p = 0.85). While multivariate subset analyses of each procedure showed a statistically slightly elevated risk of bleeding, infection, bowel obstruction, Clavien-Dindo I-III complications, and ICU admission for the liver group patients (odds ratios ranged from 1.42–1.76), rates of complications were clinically very low (3.1% and 0.8% for Clavien-Dindo I-III and IV). Conclusion Given the low 30-day complication rate, our study shows that in the appropriate candidates with mild-to-moderate chronic liver disease, minimally invasive bariatric surgery is safe in the short-term, and the documented benefits of weight loss likely outweigh the slightly elevated risk. Bariatric surgeons can feel more comfortable and informed operating in this context. Graphical AbstractKeywords
This publication has 16 references indexed in Scilit:
- Outcomes of Bariatric Surgery in Patients with Liver Cirrhosis: a Systematic ReviewObesity Surgery, 2021
- Intragastric Balloon Placement Induces Significant Metabolic and Histologic Improvement in Patients With Nonalcoholic SteatohepatitisClinical Gastroenterology and Hepatology, 2021
- AGA Clinical Practice Update on Bariatric Surgery in Cirrhosis: Expert ReviewClinical Gastroenterology and Hepatology, 2020
- Outcomes of Bariatric Surgery in Chronic Liver Disease: a National Inpatient Sample AnalysisObesity Surgery, 2019
- Effects of an intensive lifestyle intervention program on portal hypertension in patients with cirrhosis and obesity: The SportDiet studyHepatology, 2017
- The effect of underlying liver disease on short-term outcomes following bariatric surgerySurgical Endoscopy, 2014
- Increased Perioperative Mortality Following Bariatric Surgery Among Patients With CirrhosisClinical Gastroenterology and Hepatology, 2011
- Obesity is an independent risk factor for clinical decompensation in patients with cirrhosisHepatology, 2011
- Hepatic histology in obese patients undergoing bariatric surgeryJournal of Hepatology, 2006
- Effects of surgical treatment of the metabolic syndrome on liver fibrosis and cirrhosisSurgery, 2004